Manuscripts
Showing 1533 manuscripts.
Trimetrexate-leucovorin dosage evaluation study for treatment of pneumocystis carinii pneumonia
Citation
Fred Richard Sattler, Carmen Joseph Allegra, Thomas D. Verdegem, Bisher Akil, Carmelita U. Tuazon, Claire Hughlett, Debra M. Ogata-Arakaki, Judith Feinberg, James Shelhamer, H. Clifford Lane, Roger Davis, C. Thomas Boylen, John M. Leedom, Henry Masur. Trimetrexate-leucovorin dosage evaluation study for treatment of pneumocystis carinii pneumonia. Journal of Infectious Diseases. 1990. 161: 91-6.Year
1990
Journal
Journal of Infectious Diseases
Activation of complement on the surface of cells infected by human immunodeficiency virus
Citation
Greg Spear, Alan Landay, Brenda L. Sullivan, B. Dittel, T. F. Lint. Activation of complement on the surface of cells infected by human immunodeficiency virus. Journal of Immunology. 1990. 144: 1490-6.Year
1990
Journal
Journal of Immunology
Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal
Citation
Jashvant D. Unadkat, Ann C. Collier, Dana Cummings, Kent Opheim, Lawrence Corey. Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal. AIDS. 1990. 4: 229-32.Year
1990
Journal
AIDS
Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter
Citation
John G. Bartlett, Thomas C. Merigan, Paul Volberding, Newton E. Hyslop, Stephen W. Lagakos, Douglas D. Richman, Matthew A. Koch, Fred T. Valentine, Carla Pettinelli, Lawrence Corey, Maureen Myers, David K. Booth, Henry H. Balfour, Richard C. Reichman, John Alexander Bartlett, Martin S. Hirsch, Robert L. Murphy, W. David Hardy, Ruy Soeiro, Margaret A. Fischl. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. New England Journal of Medicine. 1990. 322: 941-9.Year
1990
Journal
New England Journal of Medicine
Management of cytomegalovirus disease with antiviral drugs
Citation
Henry H. Balfour. Management of cytomegalovirus disease with antiviral drugs. Reviews of Infectious Diseases. 1990. 12: S849-60.Year
1990
Journal
Reviews of Infectious Diseases
Interleukin-2 in the treatment of HIV disease
Citation
David H. Schwartz, Thomas C. Merigan. Interleukin-2 in the treatment of HIV disease. Biotherapy. 1990. 2: 119-36.Year
1990
Journal
Biotherapy
Adjusting for early treatment termination in comparative clinical trials
Citation
Stephen W. Lagakos, Lony C.L. Lim, J. Robins. Adjusting for early treatment termination in comparative clinical trials. Statistics In Medicine. 1990. 9: 1417-24.Year
1990
Journal
Statistics In Medicine
Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis
Citation
Greg Spear, Brenda L. Sullivan, Alan Landay, T. F. Lint. Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis. Journal of Virology. 1990. 64: 5869-73.Year
1990
Journal
Journal of Virology
A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients
Citation
Gildon Beall, Sally Kruger, F. Morales, D. Imagawa, J. A. Goldsmith, D. Fisher, James Paul Steinberg, John P. Phair, S. Whaling, J. Bitran. A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients. AIDS. 1990. 4: 679-81.Year
1990
Journal
AIDS
A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group
Citation
Richard B. Roberts, F. Blaine Hollinger, Wade P. Parks, Suraiya Rasheed, J. Laurence, Peter Heseltine, R. W. Makuch, J. A. Lubina, Kristine M.C. Johnson. A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group. AIDS. 1990. 4: 67-72.Year
1990
Journal
AIDS